|
|
|
7600 Japan Medical Dynamic Marketing,INC.
|
|
| 07/01/2026 15:30 |
Notice of Additional Regulatory Approval for China-Made Artificial Hip Joint Products by China WOMA and Commencement of Sales in the Chinese |
| 06/22/2026 11:00 |
Matters Concerning Controlling Shareholders, etc. |
| 06/03/2026 16:00 |
Plan to Comply with the Listing Maintenance Criteria (Market Capitalization of Tradable Shares), Including the Initiation of an Improvement |
| 05/28/2026 08:00 |
NOTICE OF CONVOCATION OF THE 54th ORDINARY GENERAL MEETING OF SHAREHOLDERS |
| 05/14/2026 08:15 |
Regarding Certain Media Reports about Our Company |
| 05/13/2026 08:30 |
Financial Results Briefing for the FYE March 2026 |
| 05/08/2026 15:30 |
Notice Regarding Differences Between the Full-Year Consolidated Financial Forecast for the FYE March 31, 2026 and the Actual Results |
| 05/08/2026 15:30 |
Consolidated Financial Results for the Fiscal Year Ended March 31, 2026(Under Japanese GAAP) |
| 03/27/2026 15:30 |
Notice Regarding Personnel Appointments for Directors Director and Audit Committee Memberand Executive Officers |
| 03/27/2026 15:30 |
Notice Regarding Transition to Company with Audit and Supervisory Committee, Change in Method of Public Notice, and Partial Amendments to the |
| 03/27/2026 15:30 |
Notice Regarding the Resignation of an Auditor and the Change in Full-Time Auditors |
| 01/30/2026 12:30 |
Consolidated Financial Results for the Nine Months Ended December 31, 2025(Under Japanese GAAP) |
| 11/12/2025 08:30 |
The Six Months Ended of Financial Results Briefing for the FYE March 2026 |
| 10/30/2025 12:30 |
Consolidated Financial Results for the Six Months Ended September 30, 2025 |
| 10/30/2025 12:30 |
Notice Regarding Revision of Consolidated Earnings Forecasts for the Full Year of the FYE March 31 2026 |
| 09/05/2025 15:45 |
Notice Regarding Revision of Consolidated Earnings Forecasts for the 2Q, and Revision of Consolidated Full Year of the FYE March, 2026 |
| 07/30/2025 12:30 |
Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 2026 [Japanese GAAP] |
|